| Literature DB >> 20738870 |
Amel Nakbi1, Wafa Tayeb, Samia Dabbou, Manel Issaoui, Abir K Grissa, Nabil Attia, Mohamed Hammami.
Abstract
BACKGROUND: Oxidative stress produced by reactive oxygen species (ROS) has been linked to the development of several diseases such as cardiovascular, cancer, and neurodegenerative diseases. This study investigates the possible protective effect of extra virgin olive oil (EVOO), lipophilic fraction (OOLF) and hydrophilic fraction (OOHF) on oxidative stress and fatty acid profile of erythrocytes in 2,4-D treated rats.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20738870 PMCID: PMC2936360 DOI: 10.1186/1476-511X-9-89
Source DB: PubMed Journal: Lipids Health Dis ISSN: 1476-511X Impact factor: 3.876
Mean values of analytical parameters, fatty acids composition (%), oxidative stability and antioxidant content of extra virgin olive oil (EVOO), hydrophilic fraction (OOHF), lipophilic fraction (OOLF) and standart diet fed to rat
| Extra virgin olive oil (EVOO) | Lipophilic fraction | Hydrophilic fraction | Standard diet | |
|---|---|---|---|---|
| Palmitic acid [%] | 10.28 ± 0.04a | 10.40 ± 0.01a | - | 11.62 ± 0.85a |
| Palmitoleic acid | 0.77 ± 0.30a | 0.79 ± 0.60a | - | 0.10 ± 0.04 a |
| Stearic acid | 3.39 ± 0.14a | 3.56 ± 0.37a | - | 1.15 ± 0.32 b |
| Oleic acid | 64.80 ± 1.99 a | 62.58 ± 3.71 a | - | 29.73 ± 1.12 b |
| Linoleic acid | 14.34 ± 0.90 b | 15.04 ± 0.54 b | - | 53.89 ± 1.49a |
| Linolenic acid | 0.64 ± 0.04a | 0.68 ± 0.03 a | - | 0.61 ± 0.02 a |
| Arachidic acid | 0.74 ± 0.05a | 0.78 ± 0.02a | - | 0.09 ± 0.04 b |
| Gadoleic acid | 0.62 ± 0.03a | 0.57 ± 0.03a | - | 0.14 ± 0.04 b |
| Behenic acid | 2.84 ± 0.37a | 2.87 ± 0.80a | - | 0.22 ± 0.10 b |
| SFA | 17.28 ± 0.22a | 17.62 ± 0.42 a | - | 13.08 ± 0.21 b |
| MUFA | 66.20 ± 2.34 a | 63.95 ± 3.07 a | - | 29.97 ± 1.32 b |
| PUFA | 14.99 ± 0.94b | 15.72 ± 0.57b | - | 54.50 ± 2.12a |
| MUFA/PUFA | 4.43 ± 0.43 a | 4.07 ± 0.04a | - | 0.54 ± 0.32 b |
| OSI (h) | 9.6a | 4.7 b | - | - |
| Chlorophylls (mg/kg) | 12.65 ± 0.29a | 5.4 ± 0.76 b | - | ND |
| β-Carotene (mg/kg) | 7.15 ± 0.20 a | 5.43 ± 0.08 b | - | ND |
| Total polyphenols (mg/kg)* | 579.17 ± 71.40a | - | 384 ± 23.18 b | ND |
| α- tocopherol (mg/kg) | 484.56 ± 11.11a | 491.64 ± 10.36a | - | 224 ± 11.86 b |
Data are expressed by mean values ± of three independent experiments. SFA: saturated fatty acids; MUFA: monounsaturated fatty acid; PUFA: polyunsaturated fatty acid; OSI: oxidative stability Index. ND: indicates not determined
Values followed by same letters are not significantly different. (Tukey's test, p < 0.05)
* As hydroxytyrosol equivalents (mg/kg EVOO)
Growth parameters of control and treated rats
| Initial body weight | Final body weight | Weight gain | |
|---|---|---|---|
| 216.80 ± 18.10 | 273.70 ± 27.10 | 26.16 ± 4.05 | |
| 220.00 ± 11.11 | 276.70 ± 15.23 | 25.62 ± 5.66 | |
| 222.80 ± 19.03 | 280.60 ± 19.77 | 26.21 ± 6.15 | |
| 222.60 ± 25.29 | 279.10 ± 34.74 | 25.32 ± 5.67 | |
| 219.10 ± 16.17 | 277.40 ± 21.66 | 26.69 ± 5.90 | |
| 221.30 ± 22.84 | 271.10 ± 22.96 | 22.81 ± 6.10 | |
| 225.50 ± 23.10 | 286.10 ± 25.86 | 27.08 ± 4.33 | |
| 221.50 ± 30.64 | 284.50 ± 29.53 | 29.82 ± 6.85 |
Data are expressed as means ± SD (n = 10 rats per group). C: controls group, D: 2, 4-D treated group, D/EVOO: 2, 4-D plus extra virgin olive oil, D/OOHF: .2, 4-D plus hydrophilic fraction, D/OOLF: .2, 4-D plus lipophilic fraction, EVOO: extra virgin olive oil treated group alone, OOHF: group treated with hydrophilic fraction of olive oil alone, OOLF: group treated with lipophilic fraction of olive oil alone. Comparison between groups was made using ANOVA one way analysis with Bonferroni test.
Figure 1Plasma MDA level in the treatment groups for 4 weeks. C: controls group, D: 2,4-D treated group at dose 5 mg/kg BW, D/EVOO: 2,4-D (5 mg/kg BW) plus extra virgin olive oil, D/OOHF: .2,4-D plus hydrophilic fraction, D/OOLF: .2,4-D plus lipophilic fraction, EVOO: extra virgin olive oil treated group alone, OOHF: group treated with hydrophilic fraction of olive oil, OOLF: group treated with lipophilic fraction of olive oil. Data are expressed as means ± SD (n = 10 rats per group). Comparison between groups was made using ANOVA with Bonferroni correction (* p < 0.05; ** p < 0.01 compared to Group D) (§§ p < 0.01 compared to controls C).
Erythrocytes antioxidants enzymes activities in control and experimental groups
| Groups | Antioxidant enzyme activity (U/g Hg) | |||
|---|---|---|---|---|
| SOD | GPx | GR | CAT | |
| 644.89 ± 28.41 | 489.05 ± 24.86 | 6.11 ± 0.40 | 1237.27 ± 46.48 | |
| 598.54 ± 18.62§ | 404.22 ± 21.72§ | 3.69 ± 1.41§ | 1093.22 ± 64.20§ | |
| 641.56 ± 14.32 | 485.97 ± 20.56* | 5.23 ± 0.84 | 1368.077 ± 113.67** | |
| 623.75 ± 71.43 | 460.18 ± 21.07 | 5.41 ± 0.69 | 1210.71 ± 53.11 | |
| 415.07 ± 94.91**§§ | 259.18 ± 25.74§§* | 3.62 ± 0.76§ | 1044.30 ± 47.37§§ | |
| 655.47 ± 24.74 | 476.91 ± 33.58 | 5.98 ± 0.68* | 1180.51 ± 53.82 | |
| 633.78 ± 29.42 | 472.49 ± 49.48 | 5.51 ± 0.75 | 1373.96 ± 71.51** | |
| 508.52 ± 80.23§ | 235.27 ± 48.06§§* | 4.42 ± 1.00§ | 1162.88 ± 85.58 | |
Data are means ± SD; n = 10 for all groups. C: controls group, D: 2, 4-D treated group, D/EVOO: 2, 4-D plus extra virgin olive oil, D/OOHF: .2, 4-D plus hydrophilic fraction, D/OOLF: .2, 4-D plus lipophilic fraction, EVOO: extra virgin olive oil treated group alone, OOHF: group treated with hydrophilic fraction of olive oil, OOLF: group treated with lipophilic fraction of olive oil. SOD: Superoxide dismutase, GPx: Glutathione peroxidase, GR: Glutathione reductase, CAT: catalase.
Comparison between groups was made using ANOVA one way analysis with Bonferroni test.
** p <.01; * p < .05 (compared to Group D)
§§ p < .01; § p < .05 (compared to controls C).
Erythrocyte membranes fatty acid composition of control and treated rats
| FA% | C | D | D/EVOO | D/OOHF | D/OOLF | EVOO | OOHF | OOLF |
|---|---|---|---|---|---|---|---|---|
| C14:0 | 2.30 ± 0.36 | 2.19 ± 0.49 | 2.08 ± 0.34 | 2.18 ± 0.33 | 2.26 ± 0.43 | 2.23 ± 0.34 | 1.94 ± 0.28 | 1.93 ± 0.30 |
| C16:0 | 25.96 ± 1.32 | 26.44 ± 1.90 | 22.34 ± 1.71§§** | 25.15 ± 1.89 | 24.17 ± 1.87 | 20.31 ± 1.15§§** | 24.41 ± 1.68 | 20.91 ± 1.74§§** |
| C18:0 | 16.54 ± 3.30 | 22.96 ± 1.26§ | 19.78 ± 1.89* | 20.94 ± 0.96* | 20.58 ± 2.03* | 15.37 ± 1.34** | 19.27 ± 1.24** | 20.80 ± 3.50* |
| C20:0 | 0.20 ± 0.04 | 0.36 ± 0.09§§ | 0.21 ± 0.06** | 0.19 ± 0.08** | 0.41 ± 0.08§§ | 0.22 ± 0.05** | 0.21 ± 0.12** | 0.39 ± 0.05§§ |
| C22:0 | 1.04 ± 0.24 | 1.65 ± 0.47§ | 0.86 ± 0.21** | 1.21 ± 0.32 | 1.24 ± 0.40 | 1.14 ± 0.26 | 1.53 ± 0.38 | 1.16 ± 0.15 |
| C24:0 | 0.94 ± 0.26 | 1.11 ± 0.36 | 0.92 ± 0.37 | 0.54 ± 0.21* | 1.13 ± 0.44 | 0.95 ± 0.42 | 0.47 ± 0.21§** | 1.12 ± 0.63 |
| C14:1 | 0.55 ± 0.14 | 0.71 ± 0.15 | 0.76 ± 0.16 | 0.74 ± 0.11 | 0.54 ± 0.12 | 0.73 ± 0.09 | 0.55 ± 0.12 | 0.64 ± 0.10 |
| C16:1 | 0.40 ± 0.06 | 0.33 ± 0.07 | 0.63 ± 0.07§** | 0.53 ± 0.09* | 0.38 ± 0.05 | 0.57 ± 0.05§** | 0.51 ± 0.05** | 0.34 ± 0.06 |
| C18:1 | 17.15 ± 0.19 | 15.67 ± 1.10 | 19.64 ± 1.33* | 15.54 ± 1.17 | 16.08 ± 1.35 | 21.88 ± 0.96§§** | 17.74 ± 0.37 | 19.30 ± 1.14§* |
| C20:1 | 0.23 ± 0.07 | 0.20 ± 0.06 | 1.06 ± 0.18§§** | 0.40 ± 0.12§* | 0.22 ± 0.08 | 0.42 ± 0.12§* | 1.35 ± 0.40§§** | 0.38 ± 0.05§* |
| C22:1 | 0.18 ± 0.04 | 0.09 ± 0.03§ | 1.13 ± 0.23§ | 0.46 ± 0.11§§ | 0.20 ± 0.03** | 0.87 ± 0.24 | 1.5 ± 0.24§§** | 1.67 ± 0.56§* |
| C24:1 | 1.62 ± 0.16 | 0.89 ± 0.25§ | 1.97 ± 0.56* | 1.44 ± 0.39 | 1.37 ± 0.39 | 2.27 ± 0.46* | 1.27 ± 0.28 | 1.66 ± 0.73 |
| C18:2 | 11.76 ± 0.84 | 11.19 ± 0.82 | 11.41 ± 0.74 | 11.53 ± 0.48 | 11.50 ± 0.21 | 11.58 ± 0.66 | 11.83 ± 1.32 | 11.44 ± 0.39 |
| C18:3w3ALA | 0.36 ± 0.09 | 0.39 ± 0.1 | 0.48 ± 0.04 | 0.39 ± 0.05 | 0.49 ± 0.04 | 0.43 ± 0.09 | 0.40 ± 0.18 | 0.65 ± 0.14§§* |
| C20:2 | 0.29 ± 0.10 | 0.52 ± 0.20§ | 0.36 ± 0.13 | 0.30 ± 0.10* | 0.79 ± 0.18§§* | 0.36 ± 0.10 | 0.34 ± 0.11 | 0.57 ± 0.17§§ |
| C20:3 | 0.40 ± 0.14 | 0.24 ± 0.07 | 0.41 ± 0.17 | 0.29 ± 0.10 | 0.60 ± 0.24* | 0.56 ± 0.25* | 0.52 ± 0.14* | 0.63 ± 0.37* |
| C20:4 | 14.39 ± 2.03 | 14.45 ± 1.81 | 11.35 ± 1.70§§** | 13.57 ± 1.85 | 12.81 ± 1.47 | 11.20 ± 1.48§§** | 14.17 ± 1.82 | 12.76 ± 1.51 |
| C20:5w3EPA | 0.31 ± 0.16 | 0.35 ± 0.19 | 0.39 ± 0.02 | 0.46 ± 0.12 | 0.33 ± 0.14 | 0.73 ± 0.12§§* | 0.63 ± 0.12§§* | 0.73 ± 0.14§§* |
| C22:4 | 0.82 ± 0.19 | 0.32 ± 0.08§§ | 0.67 ± 0.05** | 1.08 ± 0.15§** | 1.21 ± 0.19§** | 1.05 ± 0.30* | 0.68 ± 0.16* | 1.25 ± 0.23§** |
| C22:5w3DPA | 0.67 ± 0.24 | 0.18 ± 0.07§§ | 0.80 ± 0.15** | 0.30 ± 0.17§ | 0.23 ± 0.14§ | 1.03 ± 0.27§** | 0.29 ± 0.16§ | 0.29 ± 0.15§ |
| C22:6w3DHA | 1.34 ± 0.31 | 0.20 ± 0.07§§ | 0.94 ± 0.20** | 1.98 ± 0.46§** | 1.48 ± 0.43** | 1.84 ± 0.42** | 1.36 ± 0.25** | 1.05 ± 0.26** |
| PUFA/MUFA | 1.50 ± 0.10 | 1.55 ± 0.11 | 1.06 ± 0.12§§** | 1.56 ± 0.15 | 1.56 ± 0.13 | 1.07 ± 0.10§§** | 1.31 ± 0.04 | 1.22 ± 0.07§§** |
| PUFA/SFA | 0.64 ± 0.05 | 0.50 ± 0.05§§ | 0.58 ± 0.05*§ | 0.59 ± 0.03* | 0.59 ± 0.04* | 0.71 ± 0.03§** | 0.63 ± 0.04** | 0.63 ± 0.07** |
| UFA/SFA | 0.88 ± 0.06 | 0.64 ± 0.05§§ | 0.84 ± 0.08* | 0.79 ± 0.04 | 0.72 ± 0.10 | 1.04 ± 0.18§** | 0.77 ± 0.08 | 0.95 ± 0.05** |
Data are means ± SD; n = 10 for all groups. C: controls group, D: 2, 4-D treated group, D/EVOO: 2, 4-D plus extra virgin olive oil, D/OOHF: .2, 4-D plus hydrophilic fraction, D/OOLF: 2,4-D plus lipophilic fraction, EVOO: extra virgin olive oil treated group alone, OOHF: group treated with hydrophilic fraction of olive oil, OOLF: group treated with lipophilic fraction of olive oil.
SFA: Saturated fatty acid, MUFA: monounsaturated fatty acid, PUFA: polyunsaturated fatty acid, UFA: unsaturated fatty acid
** p <.01; *p < .05 (compared to Group D); §§ p < .01; § p < .05 (compared to controls C)
Comparison between groups was made using ANOVA one way analysis with Bonferroni test
Figure 2Chemical structure of 2,4-D.